SCHEMBL17340709

SCHEMBL17340709

CC(C)(C)OC(=O)Oc1ccc(C(c2ccc(OC(=O)OC(C)(C)C)cc2)c2ccc3ccc(C(c4ccc(OC(=O)OC(C)(C)C)cc4)c4ccc(OC(=O)OC(C)(C)C)cc4)cc3c2)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ELANE P08246 2/20 0.54
KDM1A O60341 1/20 0.41
CA2 P00918 1/20 0.41
AKR1C3 P42330 7/20 0.37
AKR1C2 P52895 7/20 0.37
PTGS2 P35354 3/20 0.37
TSHR P16473 3/20 0.37
PTGS1 P23219 3/20 0.37
CDC42 P60953 1/20 0.37
RAC1 P63000 1/20 0.37
CYP1A2 P05177 1/20 0.37
SLC22A6 Q4U2R8 1/20 0.37
LMNA P02545 2/20 0.37
CYP2C9 P11712 2/20 0.37
KDM4E B2RXH2 2/20 0.37
ABCB11 O95342 1/20 0.37
ESR1 P03372 1/20 0.37
CYP3A4 P08684 1/20 0.37
ADRA2A P08913 1/20 0.37
PDE4A P27815 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL197179 0.89 ELANE (0.66) ELANEKDM1ACA2TSHRLMNA
SCHEMBL13098215 0.83 ELANE (0.58) ELANEKDM1ACA2TSHRCYP1A2
SCHEMBL13098197 0.83 ELANE (0.58) ELANEKDM1ACA2TSHRCYP1A2
SCHEMBL14388570 0.83 ELANE (0.63) ELANEKDM1ACA2TSHRLMNA
SCHEMBL4056333 0.81 ELANE (0.64) ELANEKDM1ACA2LMNACYP2C9
SCHEMBL4061539 0.79 ELANE (0.65) ELANEKDM1ACA2LMNAKDM4E
SCHEMBL4061370 0.79 ELANE (0.81) ELANEKDM1ACA2LMNAMAPT
SCHEMBL17369589 0.77 TDP1 (0.51) ELANECA2AKR1C3AKR1C2PTGS2
SCHEMBL17468465 0.76 ELANE (0.62) ELANEKDM1ACA2TSHRLMNA
SCHEMBL4055008 0.76 ELANE (0.57) ELANEKDM1ACA2CYP1A2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10377734-B2 Resist composition, method for forming resist pattern, polyphenol derivative for use in the composition MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2019-08-13 US disclosed
US-20150376157-A1 RESIST COMPOSITION, METHOD FOR FORMING RESIST PATTERN, POLYPHENOL DERIVATIVE FOR USE IN THE COMPOSITION MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2015-12-31 US disclosed
US-20150376157-A1 RESIST COMPOSITION, METHOD FOR FORMING RESIST PATTERN, POLYPHENOL DERIVATIVE FOR USE IN THE COMPOSITION MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2015-12-31 US disclosed
EP-2955575-A1 RESIST COMPOSITION, RESIST PATTERN FORMATION METHOD, AND POLYPHENOL DERIVATIVE USED IN SAME Mitsubishi Gas Chemical Company, Inc. (JP) 2015-12-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150376157-A1 RESIST COMPOSITION, METHOD FOR FORMING RESIST PATTERN, POLYPHENOL DERIVATIVE FOR USE IN THE COMPOSITION HEATR1, HSP90AB1, HSP90AA1 ELANE 4505/4885KDM1A 1395/4885CA2 4000/4885
US-10377734-B2 Resist composition, method for forming resist pattern, polyphenol derivative for use in the composition HEATR1, HSP90AB1, HSP90AA1 ELANE 4505/4885KDM1A 1395/4885CA2 4000/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.